
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
T-FABP CRISPR/Cas9 KO Plasmid (m) | sc-423411 | 20 µg | $397.00 |
Fabp9 encodes testis fatty acid–binding protein (T-FABP), a lipid chaperone implicated in intracellular trafficking of long-chain fatty acids and other hydrophobic ligands in the male germline. By regulating fatty acid uptake, sequestration, and delivery to metabolic enzymes and membranes, T-FABP is linked to lipid homeostasis pathways that influence mitochondrial β-oxidation, membrane remodeling, and redox balance during spermatogenesis. Altered FABP family activity is broadly associated with metabolic dysregulation and inflammatory signaling, and Fabp9 is commonly studied in the context of sperm development, motility, and fertility-related phenotypes. In mouse models, Fabp9 provides a tractable node to interrogate how germ cell lipid handling impacts reproductive biology and stress-responsive metabolic adaptation.
T-FABP CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Fabp9 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Fabp9 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Fabp9 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish T-FABP protein expression.
This CRISPR knockout system enables efficient generation of Fabp9-deficient cell models for investigation of T-FABP signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.